<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> form a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> whose incidence is rising in elderly subjects </plain></SENT>
<SENT sid="1" pm="."><plain>While most cases are accessible to treatment with chemotherapy, elderly patients tolerate treatments less well than younger ones </plain></SENT>
<SENT sid="2" pm="."><plain>Nevertheless, treatment efficacy does not seem different </plain></SENT>
<SENT sid="3" pm="."><plain>Two approaches can thus be proposed: the first is to give the patient a conventional treatment with a higher risk of toxicity, the second one would be to propose a "lighter", dose-adapted treatment </plain></SENT>
<SENT sid="4" pm="."><plain>Two examples are examined more closely: diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>